ROS1 and central nervous system cancer: Additional less frequently reported alterations were detected in infiltrating gliomas including an NTRK2-ETV6 fusion (1 IDH-mutant astrocytoma) and ROS1-GOPC fusions (2 in IDH-wildtype infiltrating astrocytomas).